辛伐他汀
药理学
化学
CYP3A4型
代谢物
IC50型
药代动力学
没食子酸表没食子酸酯
微粒体
酶
细胞色素P450
生物化学
体外
抗氧化剂
医学
多酚
作者
Wei Yang,Qiuyang Zhang,Yue Yang,Jiaqiu Xu,Ali Fan,Chung S. Yang,Ning Li,Yang Lu,Jiayin Chen,Di Zhao,Jiye Aa,Xijing Chen
出处
期刊:Xenobiotica
[Taylor & Francis]
日期:2016-04-06
卷期号:47 (1): 86-92
被引量:12
标识
DOI:10.3109/00498254.2016.1159747
摘要
1. This study aimed to investigate the potential impact of epigallocatechin-3-gallate (EGCG) on the pharmacokinetic behaviors of simvastatin and its metabolite simvastatin acid and explored the possible role of metabolizing enzymes and transporters of this food-drug interaction. 2. Female SD rats were intravenously administered with EGCG (5 mg/kg), ketoconazole (10 mg/kg) and rifampin (10 mg/kg), followed by intravenous administration of 2 mg/kg simvastatin. In vitro, the effects of EGCG on Cytochrome P450 enzymes (CYP450) and organic anion transporting polypeptides (OATPs) were studied using human hepatic microsomes and human embryonic kidney 293 (HEK293) cells overexpressing OATP1B1 or OATP1B3. The results showed that areas under concentration-time (AUC) curves of simvastatin and simvastatin acid increased by 2.21- and 1.4-fold while the clearance was reduced by 2.29- and 1.4-fold, respectively, when co-administered with EGCG. In vitro experiments suggested the inhibitory effect of EGCG on CYP enzymes (IC50: 18.37 ± 1.36 μM, 26.08 ± 1.51 μM for simvastatin and simvastatin acid, respectively). Simvastatin transport by OATP1B1 and OATP1B3 was also inhibited by EGCG (IC50: 8.68 ± 1.27 μM and 22.67 ± 1.42 μM, respectively). 3. The presently reported novel food-drug interaction between EGCG and simvastatin involves the inhibition of not only CYP450 enzymes but also OATPs by EGCG.
科研通智能强力驱动
Strongly Powered by AbleSci AI